Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-31 Purchase | 2023-04-04 07:00 am | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 747 | $3.56 | $2,659 | 614,206 (Indirect Direct) | View |
| 2022-11-30 Purchase | 2023-03-03 4:11 pm | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 6,200 | $2.8556 | $17,705 | 623,404 (Indirect Direct) | View |
| 2023-02-01 Purchase | 2023-02-02 2:49 pm | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 400 | $3.1034 | $1,241 | 522,859 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-30 09:33 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 200 | $3.01 | $602 | 522,459 (Direct) | View |
| 2023-01-20 Purchase | 2023-01-24 12:27 pm | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 200 | $3.135 | $627 | 522,259 (Direct) | View |
| 2023-01-18 Purchase | 2023-01-20 08:19 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 400 | $3.1108 | $1,244 | 522,059 (Direct) | View |
| 2023-01-09 Purchase | 2023-01-10 6:06 pm | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 100 | $3.08 | $308 | 521,659 (Direct) | View |
| 2022-12-23 Purchase | 2022-12-28 08:22 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 300 | $3.01 | $903 | 521,559 (Direct) | View |
| 2022-12-07 Purchase | 2022-12-07 6:04 pm | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 1,800 | $2.9861 | $5,375 | 521,259 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-21 5:14 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 943 | $2.6162 | $2,467 | 513,801 (Indirect Direct) | View |
| 2022-11-18 Purchase | 2022-11-21 07:49 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 1,000 | $2.8765 | $2,877 | 519,459 (Direct) | View |
| 2022-10-12 Purchase | 2022-10-12 2:01 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 725 | $3.3884 | $2,457 | 512,858 (Indirect Direct) | View |
| 2022-10-11 Purchase | 2022-10-12 08:54 am | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 806 | $3.6886 | $2,973 | 512,133 (Indirect Direct) | View |
| 2022-09-23 Purchase | 2022-09-27 5:23 pm | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 300 | $2.8299 | $849 | 617,204 (Indirect Direct) | View |
| 2022-09-22 Purchase | 2022-09-23 09:55 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 200 | $2.92 | $584 | 518,459 (Direct) | View |
| 2022-08-26 Purchase | 2022-09-09 6:17 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 5,723 | $3.2809 | $18,777 | 511,327 (Indirect Direct) | View |
| 2022-08-26 Sale | 2022-09-09 6:17 pm | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 3,958 | $3.388 | $13,410 | 511,327 (Indirect Direct) | View |
| 2022-07-06 Purchase | 2022-07-15 11:46 am | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 1,200 | $3.0092 | $3,611 | 616,904 (Indirect Direct) | View |
| 2022-07-12 Purchase | 2022-07-13 08:25 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 700 | $2.95 | $2,065 | 518,259 (Direct) | View |
| 2022-06-30 Purchase | 2022-07-05 6:10 pm | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 1,900 | $3.0789 | $5,850 | 615,704 (Indirect Direct) | View |
| 2022-06-30 Purchase | 2022-07-01 09:20 am | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 1,100 | $3.0981 | $3,408 | 517,559 (Direct) | View |
| 2022-06-17 Purchase | 2022-06-23 3:42 pm | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 700 | $3.7856 | $2,650 | 613,804 (Indirect Direct) | View |
| 2022-06-15 Purchase | 2022-06-17 5:05 pm | BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner | 3,200 | $3.7734 | $12,075 | 613,104 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-20 Tax Withholding | 2023-03-22 4:49 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 6,729 | $2.92 | 613,459 (Direct) | View |
| 2023-03-20 Tax Withholding | 2023-03-22 4:47 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner | 6,729 | $2.92 | 622,518 (Direct) | View |
| 2023-02-18 Tax Withholding | 2023-02-28 07:26 am | N/A N/A | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 374 | $2.99 | 620,188 (Direct) | View |
| 2023-02-18 Tax Withholding | 2023-02-27 5:17 pm | N/A N/A | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner | 374 | $2.99 | 629,247 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 9:39 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance | 88,968 | $0 | 97,245 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:38 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Rosa David A Director | 32,028 | $0 | 42,518 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:36 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director | 32,028 | $0 | 42,518 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:33 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director | 32,028 | $0 | 57,264 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:32 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer | 88,968 | $0 | 107,452 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:29 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner | 106,762 | $0 | 620,562 (Direct) | View |
| 2023-02-17 Option Award | 2023-02-17 5:27 pm | N/A 2033-02-17 | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner | 106,762 | $0 | 629,621 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:28 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance | 8,277 | $0 | 8,277 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:28 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance | 8,277 | $0 | 8,277 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:27 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 335,538 | $0 | 512,858 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:27 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development | 335,538 | $0 | 512,858 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:24 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer | 10,490 | $0 | 18,484 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:24 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer | 10,490 | $0 | 18,484 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:22 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director | 25,236 | $0 | 25,236 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:22 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director | 25,236 | $0 | 25,236 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:19 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director | 10,490 | $0 | 10,490 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:19 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director | 10,490 | $0 | 10,490 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:18 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Rosa David A Director | 10,490 | $0 | 10,490 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:18 pm | N/A 2031-11-04 | BioRestorative Therapies Inc. | BRTX | Rosa David A Director | 10,490 | $0 | 10,490 (Direct) | View |
| 2022-11-03 Option Award | 2022-11-04 4:16 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 335,538 | $0 | 518,459 (Direct) | View |
| 2022-11-03 Disposition | 2022-11-04 4:16 pm | N/A 2031-03-18 | BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB | 335,538 | $0 | 518,459 (Direct) | View |